Manipulation of the innate immune response by human papillomaviruses

Virus Research

Volumn 231, Issue , 2017, Pages 34-40

  Hong, Shiyuan ^a   Laimins, Laimonis A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Inflammasome; Interferons; JAK STAT pathway; PAMPs

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; JANUS KINASE; STAT5 PROTEIN; VIRAL PROTEIN; ATM PROTEIN, HUMAN; ATR PROTEIN, HUMAN; ONCOPROTEIN;

DNA DAMAGE RESPONSE; HOST; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; LIFE CYCLE; MOLECULAR SENSOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION; WART VIRUS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNE EVASION; IMMUNOLOGY; KERATINOCYTE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; VIROLOGY; VIRUS GENOME; VIRUS REPLICATION;

ATAXIA TELANGIECTASIA MUTATED PROTEINS; GENE EXPRESSION REGULATION; GENOME, VIRAL; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INTERFERONS; JANUS KINASES; KERATINOCYTES; NF-KAPPA B; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; VIRUS REPLICATION;

EID: 85006852231     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.11.004     Document Type: Review

References (60)

1. Abbas, A.K., Lichtman, A.H., Pillai, S., Cellular and Molecular Immunology. eighth edition, 2015, ELSEVIER SAUNDERS.
2. An, J., Mo, D., Liu, H., Veena, M.S., Srivatsan, E.S., Massoumi, R., Rettig, M.B., Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell 14 (2008), 394–407, 10.1016/j.ccr.2008.10.007.
3. Barnard, P., McMillan, N.A., The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha. Virology 259 (1999), 305–313, 10.1006/viro.1999.9771.
4. Bodily, J., Laimins, L.A., Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol. 19 (2011), 33–39, 10.1016/j.tim.2010.10.002.
5. Cannella, F., Pierangeli, A., Scagnolari, C., Cacciotti, G., Tranquilli, G., Stentella, P., Recine, N., Antonelli, G., TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections. Immunobiology 220 (2015), 363–368, 10.1016/j.imbio.2014.10.012.
6. Chan, Y.K., Gack, M.U., Viral evasion of intracellular DNA and RNA sensing. Nat. Rev. Microbiol. 14 (2016), 360–373, 10.1038/nrmicro.2016.45.
7. Chang, Y.E., Laimins, L.A., Microarray analysis identifies interferon-inducible genes and Stat-1 as major transcriptional targets of human papillomavirus type 31. J. Virol. 74 (2000), 4174–4182.
8. Chen, I.-Y., Ichinohe, T., Response of host inflammasomes to viral infection. Trends Microbiol. 23 (2015), 55–63, 10.1016/j.tim.2014.09.007.
9. Cheon, H., Stark, G.R., Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 9373–9378, 10.1073/pnas.0903487106.
10. Cicchini, L., Westrich, J.A., Xu, T., Vermeer, D.W., Berger, J.N., Clambey, E.T., Lee, D., Song, J.I., Lambert, P.F., Greer, R.O., Lee, J.H., Pyeon, D., Suppression of antitumor immune responses by human papillomavirus through epigenetic downregulation of CXCL14. MBio, 7, 2016, 10.1128/mBio. 00270-16 e00270-16.
11. Lo Cigno, I., De Andrea, M., Borgogna, C., Albertini, S., Landini, M.M., Peretti, A., Johnson, K.E., Chandran, B., Landolfo, S., Gariglio, M., The nuclear DNA sensor IFI16 acts as a restriction factor for human papillomavirus replication through epigenetic modifications of the viral promoters. J. Virol. 89 (2015), 7506–7520, 10.1128/JVI. 00013-15.
12. Cordano, P., Gillan, V., Bratlie, S., Bouvard, V., Banks, L., Tommasino, M., Campo, M.S., The E6E7 oncoproteins of cutaneous human papillomavirus type 38 interfere with the interferon pathway. Virology 377 (2008), 408–418, 10.1016/j.virol.2008.04.036.
13. Diamond, M.S., Farzan, M., The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13 (2013), 46–57, 10.1038/nri3344.
14. Doan, T., Melvold, R., Viselli, S., Waltenbaugh, C., Lippincott's Illustrated Reviews: Immunology. 2008, Wolters Kluwer Health/Lippincott Williams & Wilkins.
15. Dyson, N., Howley, P.M., Munger, K., Harlow, E., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 (1989), 934–937.
16. Fan, Z., Cui, H., Xu, X., Lin, Z., Zhang, X., Kang, L., Han, B., Meng, J., Yan, Z., Yan, X., Jiao, S., MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3. Oncotarget 6 (2015), 25266–25280, 10.18632/oncotarget.4457.
17. Gao, D., Wu, J., Wu, Y.-T., Du, F., Aroh, C., Yan, N., Sun, L., Chen, Z.J., Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341 (2013), 903–906, 10.1126/science.1240933.
18. Guo, Z., Linn, J.F., Wu, G., Anzick, S.L., Eisenberger, C.F., Halachmi, S., Cohen, Y., Fomenkov, A., Hoque, M.O., Okami, K., Steiner, G., Engles, J.M., Osada, M., Moon, C., Ratovitski, E., Trent, J.M., Meltzer, P.S., Westra, W.H., Kiemeney, L.A., Schoenberg, M.P., Sidransky, D., Trink, B., CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat. Med. 10 (2004), 374–381, 10.1038/nm1010.
19. Hasan, U.A., Zannetti, C., Parroche, P., Goutagny, N., Malfroy, M., Roblot, G., Carreira, C., Hussain, I., Müller, M., Taylor-Papadimitriou, J., Picard, D., Sylla, B.S., Trinchieri, G., Medzhitov, R., Tommasino, M., The human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J. Exp. Med. 210 (2013), 1369–1387, 10.1084/jem.20122394.
20. zur Hausen, H., Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 (2002), 342–350, 10.1038/nrc798.
21. Hebner, C.M., Laimins, L.A., Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16 (2006), 83–97, 10.1002/rmv.488.
22. Hebner, C.M., Wilson, R., Rader, J., Bidder, M., Laimins, L.A., Human papillomaviruses target the double-stranded RNA protein kinase pathway. J. Gen. Virol. 87 (2006), 3183–3193, 10.1099/vir.0. 82098-0.
23. Hebner, C., Beglin, M., Laimins, L.A., Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation. J. Virol. 81 (2007), 12740–12747, 10.1128/JVI. 00987-07.
24. Heltemes-Harris, L.M., Farrar, M.A., The role of STAT5 in lymphocyte development and transformation. Curr. Opin. Immunol. 24 (2012), 146–152, 10.1016/j.coi.2012.01.015.
25. Hong, S., Laimins, L.A., The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation. PLoS Pathog., 9, 2013, e1003295, 10.1371/journal.ppat.1003295.
26. Hong, S., Mehta, K.P., Laimins, L.A., Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance. J. Virol. 85 (2011), 9486–9494, 10.1128/JVI.05007-11.
27. Hong, S., Dutta, A., Laimins, L.A., The acetyltransferase Tip60 is a critical regulator of the differentiation-dependent amplification of human papillomaviruses. J. Virol. 89 (2015), 4668–4675, 10.1128/JVI. 03455-14.
28. Huang, S.-M., McCance, D.J., Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF. J. Virol. 76 (2002), 8710–8721, 10.1128/JVI.76.17.
29. Huibregtse, J.M., Scheffner, M., Howley, P.M., A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10 (1991), 4129–4135.
30. Kazemi, S., Papadopoulou, S., Li, S., Su, Q., Wang, S., Yoshimura, A., Matlashewski, G., Dever, T.E., Koromilas, A.E., Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death. Mol. Cell Biol. 24 (2004), 3415–3429, 10.1128/MCB.24.8.
31. Lace, M.J., Anson, J.R., Haugen, T.H., Turek, L.P., Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes. Virology 399 (2010), 270–279, 10.1016/j.virol.2009.12.025.
32. Li, S., Labrecque, S., Gauzzi, M.C., Cuddihy, A.R., Wong, A.H., Pellegrini, S., Matlashewski, G.J., Koromilas, A.E., The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18 (1999), 5727–5737, 10.1038/sj.onc.1202960.
33. Longworth, M.S., Wilson, R., Laimins, L.A., HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J. 24 (2005), 1821–1830, 10.1038/sj.emboj.7600651.
34. Loo, Y.-M., Gale, M., Immune signaling by RIG-I-like receptors. Immunity 34 (2011), 680–692, 10.1016/j.immuni.2011.05.003.
35. Mazibrada, J., Longo, L., Vatrano, S., Cappia, S., Giorcelli, J., Pentenero, M., Gandolfo, S., Volante, M., dell'Oste, V., Cigno Lo, I., Biolatti, M., Landolfo, S., Papotti, M., Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis. New Microbiol. 37 (2014), 129–143.
36. Moody, C.A., Laimins, L.A., Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog., 5, 2009, e1000605, 10.1371/journal.ppat.1000605.
37. Munger, K., Howley, P.M., Human papillomavirus immortalization and transformation functions. Virus Res. 89 (2002), 213–228.
38. Munger, K., Werness, B.A., Dyson, N., Phelps, W.C., Harlow, E., Howley, P.M., Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8 (1989), 4099–4105.
39. Murphy, N., Ring, M., Heffron, C.C.B.B., King, B., Killalea, A.G., Hughes, C., Martin, C.M., McGuinness, E., Sheils, O., O'Leary, J.J., p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J. Clin. Pathol. 58 (2005), 525–534, 10.1136/jcp.2004.018895.
40. Nees, M., Geoghegan, J.M., Hyman, T., Frank, S., Miller, L., Woodworth, C.D., Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes. J. Virol. 75 (2001), 4283–4296, 10.1128/JVI.75.9.4283-4296.2001.
41. Niebler, M., Qian, X., Höfler, D., Kogosov, V., Kaewprag, J., Kaufmann, A.M., Ly, R., Böhmer, G., Zawatzky, R., Rösl, F., Rincon-Orozco, B., Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog., 9, 2013, e1003536, 10.1371/journal.ppat.1003536.
42. Oldak, M., Tolzmann, L., Wnorowski, A., Podgórska, M.J., Silling, S., Lin, R., Hiscott, J., Müller, C.S.L., Vogt, T., Smola, H., Smola, S., Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7. J. Virol. 85 (2011), 178–188, 10.1128/JVI. 00998-10.
43. Pacini, L., Savini, C., Ghittoni, R., Saidj, D., Lamartine, J., Hasan, U.A., Accardi, R., Tommasino, M., Downregulation of toll-like receptor 9 expression by beta human papillomavirus 38 and implications for cell cycle control. J. Virol. 89 (2015), 11396–11405, 10.1128/JVI. 02151-15.
44. Park, J.S., Kim, E.J., Kwon, H.J., Hwang, E.S., Namkoong, S.E., Um, S.J., Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275 (2000), 6764–6769.
45. Rajsbaum, R., García-Sastre, A., Versteeg, G.A., TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J. Mol. Biol. 426 (2014), 1265–1284, 10.1016/j.jmb.2013.12.005.
46. Reinholz, M., Kawakami, Y., Salzer, S., Kreuter, A., Dombrowski, Y., Koglin, S., Kresse, S., Ruzicka, T., Schauber, J., HPV16 activates the AIM2 inflammasome in keratinocytes. Arch. Dermatol. Res. 305 (2013), 723–732, 10.1007/s00403-013-1375-0.
47. Reiser, J., Hurst, J., Voges, M., Krauss, P., Münch, P., Iftner, T., Stubenrauch, F., High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J. Virol. 85 (2011), 11372–11380, 10.1128/JVI. 05279-11.
48. Richards, K.H., Wasson, C.W., Watherston, O., Doble, R., Blair, G.E., Wittmann, M., Macdonald, A., The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes. Sci. Rep., 5, 2015, 12922, 10.1038/srep12922.
49. Rincon-Orozco, B., Halec, G., Rosenberger, S., Muschik, D., Nindl, I., Bachmann, A., Ritter, T.M., Dondog, B., Ly, R., Bosch, F.X., Zawatzky, R., Rösl, F., Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Cancer Res. 69 (2009), 8718–8725, 10.1158/0008-5472.CAN-09-0550.
50. Ronco, L.V., Karpova, A.Y., Vidal, M., Howley, P.M., Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12 (1998), 2061–2072.
51. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., Howley, P.M., The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990), 1129–1136.
52. Scheffner, M., Huibregtse, J.M., Vierstra, R.D., Howley, P.M., The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 (1993), 495–505.
53. Seth, R.B., Sun, L., Chen, Z.J., Antiviral innate immunity pathways. Cell Res. 16 (2006), 141–147, 10.1038/sj.cr.7310019.
54. Shukla, S., Mahata, S., Shishodia, G., Pandey, A., Tyagi, A., Vishnoi, K., Basir, S.F., Das, B.C., Bharti, A.C., Functional regulatory role of STAT3 in HPV16-mediated cervical carcinogenesis. PLoS ONE, 8, 2013, e67849, 10.1371/journal.pone.0067849.
55. Spitkovsky, D., Hehner, S.P., Hofmann, T.G., Möller, A., Schmitz, M.L., The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. J. Biol. Chem. 277 (2002), 25576–25582, 10.1074/jbc.M201884200.
56. Sun, L., Wu, J., Du, F., Chen, X., Chen, Z.J., Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339 (2013), 786–791, 10.1126/science.1232458.
57. Takaoka, A., Wang, Z., Choi, M.K., Yanai, H., Negishi, H., Ban, T., Lu, Y., Miyagishi, M., Kodama, T., Honda, K., Ohba, Y., Taniguchi, T., DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448 (2007), 501–505, 10.1038/nature06013.
58. Terenzi, F., Saikia, P., Sen, G.C., Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J. 27 (2008), 3311–3321, 10.1038/emboj.2008.241.
59. Tyagi, A., Vishnoi, K., Mahata, S., Verma, G., Srivastava, Y., Masaldan, S., Roy, B.G., Bharti, A.C., Das, B.C., Cervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self-renewal through upregulation of HES1. Clin. Cancer Res. 22 (2016), 4170–4184, 10.1158/1078-0432.CCR-15-2574.
60. Warren, C.J., Griffin, L.M., Little, A.S., Huang, I.-C., Farzan, M., Pyeon, D., The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS ONE, 9, 2014, e96579, 10.1371/journal.pone.0096579.